Subconjunctival corticosteroid injection for the treatment of non-necrotising anterior scleritis
Patient age, sex Scleritis type Associated disease Systemic treatment before SCI Side effects from systemic treatment Prednisone dose followed by relapse before SCI Duration of scleritis before SCI (months) Systemic treatment after SCI (last follow up) Follow up (months) Side effects from SCI 1, 57,...
Gespeichert in:
Veröffentlicht in: | British journal of ophthalmology 2005-07, Vol.89 (7), p.917-918 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 918 |
---|---|
container_issue | 7 |
container_start_page | 917 |
container_title | British journal of ophthalmology |
container_volume | 89 |
creator | Sen, H N Ursea, R Nussenblatt, R B Buggage, R R |
description | Patient age, sex Scleritis type Associated disease Systemic treatment before SCI Side effects from systemic treatment Prednisone dose followed by relapse before SCI Duration of scleritis before SCI (months) Systemic treatment after SCI (last follow up) Follow up (months) Side effects from SCI 1, 57, F Nodular anterior both eyes Mixed connective tissue disease (inactive) Pred 15 mg MTX 12.5 mg Osteoporosis Weight gain 7.5 mg 63 None 22 None 2, 41, M Diffuse anterior both eyes None* Pred 9 mg MMF 2 g Pneumonia 9 mg 14 Pred 4 mg MMF 2 g 19 Transient IOP increase LE 3, 56, F Diffuse anterior both eyes Sjogren's syndrome (inactive) Pred 20 mg MTX 20 mg Weight gain Myopathy Recurrent UTI GERD 15 mg 36 Pred 5 mg MTX 25 mg 17 None 4, 11, M Diffuse anterior both eyes+ Posterior left eye None Pred 50 mg CsA 150 mg Weight gain Persistent headache 50 mg 11 Pred 10 mg 5 Subconjunctival haemorrhage, Transient IOP increase LE SCI, subconjunctival injection of triamcinolone acetonide; CsA, cyclosporine; MMF, mycophenolate mofetil; Pred, prednisone; UTI, urinary tract infection; GERD, gastro-oesophageal reflux disease. |
doi_str_mv | 10.1136/bjo.2004.052738 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1772749</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4012387631</sourcerecordid><originalsourceid>FETCH-LOGICAL-b492t-3991a3dee0ed4b4dcdf6362c426e926271949ff8eb8f80b70d7262b3fc559d933</originalsourceid><addsrcrecordid>eNqFkU1v1DAQhi1ERbeFMzcUCYlDpWz9FTu-IFUroIhVEQLK0diO0zokdrGdCv49XmXVUi6cbM88886MXwCeI7hGiLBTPYQ1hpCuYYM5aR-BFaKsrTHk4jFYQQh5jRBDh-AopaE8MUP8CThEjWAN4u0KfP88axP8MHuT3a0aKxNidiakbGNwXeX8YEsm-KoPscrXtsrRqjxZn6vQVz742lsTQ3bJ-atK-VLnCpnMWC4l-hQc9GpM9tn-PAZf3775sjmvtx_fvd-cbWtNBc41EQIp0lkLbUc17UzXM8KwoZhZgRnmSFDR963Vbd9CzWHHS1ST3jSN6AQhx-D1onsz68l2pgwY1ShvoptU_C2DcvJhxrtreRVuJeIccyqKwKu9QAw_Z5uynFwydhyVt2FOknFBm4bvwJf_gEOYoy_L7bRagRhrYKFOF6p8TkrR9nejICh33snindx5JxfvSsWLvze45_dmFaBeAFfc-XWXV_FHGY7wRl5cbuSnbx_O6eZyK1HhTxZeT8N_u_8BywG0fA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1778916650</pqid></control><display><type>article</type><title>Subconjunctival corticosteroid injection for the treatment of non-necrotising anterior scleritis</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Sen, H N ; Ursea, R ; Nussenblatt, R B ; Buggage, R R</creator><creatorcontrib>Sen, H N ; Ursea, R ; Nussenblatt, R B ; Buggage, R R</creatorcontrib><description>Patient age, sex Scleritis type Associated disease Systemic treatment before SCI Side effects from systemic treatment Prednisone dose followed by relapse before SCI Duration of scleritis before SCI (months) Systemic treatment after SCI (last follow up) Follow up (months) Side effects from SCI 1, 57, F Nodular anterior both eyes Mixed connective tissue disease (inactive) Pred 15 mg MTX 12.5 mg Osteoporosis Weight gain 7.5 mg 63 None 22 None 2, 41, M Diffuse anterior both eyes None* Pred 9 mg MMF 2 g Pneumonia 9 mg 14 Pred 4 mg MMF 2 g 19 Transient IOP increase LE 3, 56, F Diffuse anterior both eyes Sjogren's syndrome (inactive) Pred 20 mg MTX 20 mg Weight gain Myopathy Recurrent UTI GERD 15 mg 36 Pred 5 mg MTX 25 mg 17 None 4, 11, M Diffuse anterior both eyes+ Posterior left eye None Pred 50 mg CsA 150 mg Weight gain Persistent headache 50 mg 11 Pred 10 mg 5 Subconjunctival haemorrhage, Transient IOP increase LE SCI, subconjunctival injection of triamcinolone acetonide; CsA, cyclosporine; MMF, mycophenolate mofetil; Pred, prednisone; UTI, urinary tract infection; GERD, gastro-oesophageal reflux disease.</description><identifier>ISSN: 0007-1161</identifier><identifier>EISSN: 1468-2079</identifier><identifier>DOI: 10.1136/bjo.2004.052738</identifier><identifier>PMID: 15965178</identifier><identifier>CODEN: BJOPAL</identifier><language>eng</language><publisher>BMA House, Tavistock Square, London, WC1H 9JR: BMJ Publishing Group Ltd</publisher><subject>Adult ; Child ; corticosteroids ; Disease ; Female ; Fluorescein Angiography ; Humans ; Immunosuppressive Agents - administration & dosage ; Injections ; Letter ; Male ; Middle Aged ; non-necrotising anterior scleritis ; Patients ; Prescription drugs ; Retrospective Studies ; Scleritis - drug therapy ; Treatment Outcome ; Triamcinolone Acetonide - administration & dosage</subject><ispartof>British journal of ophthalmology, 2005-07, Vol.89 (7), p.917-918</ispartof><rights>Copyright 2005 British Journal of Ophthalmology</rights><rights>Copyright: 2005 Copyright 2005 British Journal of Ophthalmology</rights><rights>Copyright © Copyright 2005 British Journal of Ophthalmology 2005</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b492t-3991a3dee0ed4b4dcdf6362c426e926271949ff8eb8f80b70d7262b3fc559d933</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1772749/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1772749/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,725,778,782,883,27907,27908,53774,53776</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15965178$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sen, H N</creatorcontrib><creatorcontrib>Ursea, R</creatorcontrib><creatorcontrib>Nussenblatt, R B</creatorcontrib><creatorcontrib>Buggage, R R</creatorcontrib><title>Subconjunctival corticosteroid injection for the treatment of non-necrotising anterior scleritis</title><title>British journal of ophthalmology</title><addtitle>Br J Ophthalmol</addtitle><description>Patient age, sex Scleritis type Associated disease Systemic treatment before SCI Side effects from systemic treatment Prednisone dose followed by relapse before SCI Duration of scleritis before SCI (months) Systemic treatment after SCI (last follow up) Follow up (months) Side effects from SCI 1, 57, F Nodular anterior both eyes Mixed connective tissue disease (inactive) Pred 15 mg MTX 12.5 mg Osteoporosis Weight gain 7.5 mg 63 None 22 None 2, 41, M Diffuse anterior both eyes None* Pred 9 mg MMF 2 g Pneumonia 9 mg 14 Pred 4 mg MMF 2 g 19 Transient IOP increase LE 3, 56, F Diffuse anterior both eyes Sjogren's syndrome (inactive) Pred 20 mg MTX 20 mg Weight gain Myopathy Recurrent UTI GERD 15 mg 36 Pred 5 mg MTX 25 mg 17 None 4, 11, M Diffuse anterior both eyes+ Posterior left eye None Pred 50 mg CsA 150 mg Weight gain Persistent headache 50 mg 11 Pred 10 mg 5 Subconjunctival haemorrhage, Transient IOP increase LE SCI, subconjunctival injection of triamcinolone acetonide; CsA, cyclosporine; MMF, mycophenolate mofetil; Pred, prednisone; UTI, urinary tract infection; GERD, gastro-oesophageal reflux disease.</description><subject>Adult</subject><subject>Child</subject><subject>corticosteroids</subject><subject>Disease</subject><subject>Female</subject><subject>Fluorescein Angiography</subject><subject>Humans</subject><subject>Immunosuppressive Agents - administration & dosage</subject><subject>Injections</subject><subject>Letter</subject><subject>Male</subject><subject>Middle Aged</subject><subject>non-necrotising anterior scleritis</subject><subject>Patients</subject><subject>Prescription drugs</subject><subject>Retrospective Studies</subject><subject>Scleritis - drug therapy</subject><subject>Treatment Outcome</subject><subject>Triamcinolone Acetonide - administration & dosage</subject><issn>0007-1161</issn><issn>1468-2079</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNqFkU1v1DAQhi1ERbeFMzcUCYlDpWz9FTu-IFUroIhVEQLK0diO0zokdrGdCv49XmXVUi6cbM88886MXwCeI7hGiLBTPYQ1hpCuYYM5aR-BFaKsrTHk4jFYQQh5jRBDh-AopaE8MUP8CThEjWAN4u0KfP88axP8MHuT3a0aKxNidiakbGNwXeX8YEsm-KoPscrXtsrRqjxZn6vQVz742lsTQ3bJ-atK-VLnCpnMWC4l-hQc9GpM9tn-PAZf3775sjmvtx_fvd-cbWtNBc41EQIp0lkLbUc17UzXM8KwoZhZgRnmSFDR963Vbd9CzWHHS1ST3jSN6AQhx-D1onsz68l2pgwY1ShvoptU_C2DcvJhxrtreRVuJeIccyqKwKu9QAw_Z5uynFwydhyVt2FOknFBm4bvwJf_gEOYoy_L7bRagRhrYKFOF6p8TkrR9nejICh33snindx5JxfvSsWLvze45_dmFaBeAFfc-XWXV_FHGY7wRl5cbuSnbx_O6eZyK1HhTxZeT8N_u_8BywG0fA</recordid><startdate>200507</startdate><enddate>200507</enddate><creator>Sen, H N</creator><creator>Ursea, R</creator><creator>Nussenblatt, R B</creator><creator>Buggage, R R</creator><general>BMJ Publishing Group Ltd</general><general>BMJ Publishing Group LTD</general><general>Copyright 2005 British Journal of Ophthalmology</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>200507</creationdate><title>Subconjunctival corticosteroid injection for the treatment of non-necrotising anterior scleritis</title><author>Sen, H N ; Ursea, R ; Nussenblatt, R B ; Buggage, R R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b492t-3991a3dee0ed4b4dcdf6362c426e926271949ff8eb8f80b70d7262b3fc559d933</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adult</topic><topic>Child</topic><topic>corticosteroids</topic><topic>Disease</topic><topic>Female</topic><topic>Fluorescein Angiography</topic><topic>Humans</topic><topic>Immunosuppressive Agents - administration & dosage</topic><topic>Injections</topic><topic>Letter</topic><topic>Male</topic><topic>Middle Aged</topic><topic>non-necrotising anterior scleritis</topic><topic>Patients</topic><topic>Prescription drugs</topic><topic>Retrospective Studies</topic><topic>Scleritis - drug therapy</topic><topic>Treatment Outcome</topic><topic>Triamcinolone Acetonide - administration & dosage</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sen, H N</creatorcontrib><creatorcontrib>Ursea, R</creatorcontrib><creatorcontrib>Nussenblatt, R B</creatorcontrib><creatorcontrib>Buggage, R R</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>British journal of ophthalmology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sen, H N</au><au>Ursea, R</au><au>Nussenblatt, R B</au><au>Buggage, R R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Subconjunctival corticosteroid injection for the treatment of non-necrotising anterior scleritis</atitle><jtitle>British journal of ophthalmology</jtitle><addtitle>Br J Ophthalmol</addtitle><date>2005-07</date><risdate>2005</risdate><volume>89</volume><issue>7</issue><spage>917</spage><epage>918</epage><pages>917-918</pages><issn>0007-1161</issn><eissn>1468-2079</eissn><coden>BJOPAL</coden><abstract>Patient age, sex Scleritis type Associated disease Systemic treatment before SCI Side effects from systemic treatment Prednisone dose followed by relapse before SCI Duration of scleritis before SCI (months) Systemic treatment after SCI (last follow up) Follow up (months) Side effects from SCI 1, 57, F Nodular anterior both eyes Mixed connective tissue disease (inactive) Pred 15 mg MTX 12.5 mg Osteoporosis Weight gain 7.5 mg 63 None 22 None 2, 41, M Diffuse anterior both eyes None* Pred 9 mg MMF 2 g Pneumonia 9 mg 14 Pred 4 mg MMF 2 g 19 Transient IOP increase LE 3, 56, F Diffuse anterior both eyes Sjogren's syndrome (inactive) Pred 20 mg MTX 20 mg Weight gain Myopathy Recurrent UTI GERD 15 mg 36 Pred 5 mg MTX 25 mg 17 None 4, 11, M Diffuse anterior both eyes+ Posterior left eye None Pred 50 mg CsA 150 mg Weight gain Persistent headache 50 mg 11 Pred 10 mg 5 Subconjunctival haemorrhage, Transient IOP increase LE SCI, subconjunctival injection of triamcinolone acetonide; CsA, cyclosporine; MMF, mycophenolate mofetil; Pred, prednisone; UTI, urinary tract infection; GERD, gastro-oesophageal reflux disease.</abstract><cop>BMA House, Tavistock Square, London, WC1H 9JR</cop><pub>BMJ Publishing Group Ltd</pub><pmid>15965178</pmid><doi>10.1136/bjo.2004.052738</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0007-1161 |
ispartof | British journal of ophthalmology, 2005-07, Vol.89 (7), p.917-918 |
issn | 0007-1161 1468-2079 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1772749 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection |
subjects | Adult Child corticosteroids Disease Female Fluorescein Angiography Humans Immunosuppressive Agents - administration & dosage Injections Letter Male Middle Aged non-necrotising anterior scleritis Patients Prescription drugs Retrospective Studies Scleritis - drug therapy Treatment Outcome Triamcinolone Acetonide - administration & dosage |
title | Subconjunctival corticosteroid injection for the treatment of non-necrotising anterior scleritis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T17%3A27%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Subconjunctival%20corticosteroid%20injection%20for%20the%20treatment%20of%20non-necrotising%20anterior%20scleritis&rft.jtitle=British%20journal%20of%20ophthalmology&rft.au=Sen,%20H%20N&rft.date=2005-07&rft.volume=89&rft.issue=7&rft.spage=917&rft.epage=918&rft.pages=917-918&rft.issn=0007-1161&rft.eissn=1468-2079&rft.coden=BJOPAL&rft_id=info:doi/10.1136/bjo.2004.052738&rft_dat=%3Cproquest_pubme%3E4012387631%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1778916650&rft_id=info:pmid/15965178&rfr_iscdi=true |